Cancer drug design and discovery (Record no. 7404)

MARC details
000 -LEADER
fixed length control field 01686cam a2200289 a 4500
001 - CONTROL NUMBER
control field 000024341
003 - CONTROL NUMBER IDENTIFIER
control field YEEZEN
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20230210124652.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 080403s2008 mau r 001 0 eng d
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9780123694485
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 0123694485
040 ## - CATALOGING SOURCE
Original cataloging agency NHRI
Transcribing agency 0
042 ## - AUTHENTICATION CODE
Authentication code nbic
060 #4 - NATIONAL LIBRARY OF MEDICINE CALL NUMBER
Classification number QV269
Item number N397
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Neidle, Stephen.
245 10 - TITLE STATEMENT
Title Cancer drug design and discovery
Statement of responsibility, etc. Stephen Neidle.
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Place of publication, distribution, etc. Boston
Name of publisher, distributor, etc. Academic Press
Date of publication, distribution, etc. 2008.
300 ## - PHYSICAL DESCRIPTION
Extent xv, 473 p., [27] p. of plates
Other physical details ill. (some col.)
Dimensions 27 cm.
504 ## - BIBLIOGRAPHY, ETC. NOTE
Bibliography, etc. note Includes bibliographical references and index.
505 0# - FORMATTED CONTENTS NOTE
Formatted contents note Pt. I Basic Principles.
505 0# - FORMATTED CONTENTS NOTE
Formatted contents note Pt. II Methodology.
505 0# - FORMATTED CONTENTS NOTE
Formatted contents note Pt. III Drugs in the Clinic.
505 0# - FORMATTED CONTENTS NOTE
Formatted contents note Pt. IV New Agents.
505 0# - FORMATTED CONTENTS NOTE
Formatted contents note Pt. V The Reality of Cancer Drugs in the Clinic.
520 3# - SUMMARY, ETC.
Summary, etc. The ultimate source of information on the design of new anticancer agents, emphasising small molecules, this newest work covers recent notable successes resulting from the human genome and cancer genomics projects. These advances have provided information on targets involved in specific cancers that are leading to effective medicines for at least some of the common solid tumours.
520 3# - SUMMARY, ETC.
Summary, etc. Unique sections explain the basic underlying principles of cancer drug development and provide a practical introduction to modern methods of drug design. Appealing to a broad audience, this is an excellent reference for translational researchers interested in cancer biology and medicine as well as students in pharmacy, pharmacology, or medicinal and biological chemistry, and clinicians taking oncology options.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antineoplastic agents
General subdivision Development.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antineoplastic agents
General subdivision Design.
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Source of classification or shelving scheme
Koha item type 西文圖書
Holdings
撤銷狀態 遺失狀態 分類號來源 損壞狀態 不外借 永久館藏地 現在館藏地 書架位置 採購日期 全部借出 完整索書號 條碼號 最後一次日期記錄 一般價格有效日期 Koha館藏類型
未註銷館藏 未遺失   未損毀 可外借 怡仁綜合醫院圖書館 怡仁綜合醫院圖書館   2023-02-10   QV269 E01275 2023-02-10 2023-02-10 西文圖書
怡仁醫院| 地址:32643桃園市楊梅區楊新北路321巷30號 | 服務專線:03-4855566 | 電子郵件信箱:
Copyright © 1996 CHC Hospital

Powered by Koha